Fundraising FoxNan Fung Life Sciences — 2019 Investments
1 investments dated 2019 · listed companies and verified rows first · show all
Bolt Biotherapeuticsboltbio.comin𝕏NASDAQ: BOLTFeb 2019 · $54M
Bolt Biotherapeutics is a clinical-stage biotech company developing novel immunotherapies that leverage innate immune system mechanisms to treat cancer.
BiotechHealthtechMedical DevicesSan Francisco, US
Dr. Edgar G. Engleman(Founder)
Co-investorsPfizer Venture InvestmentsPivotal Life SciencesRA CapitalSamsara BioCapitalSofinnova VenturesVivo Capital+3 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.